These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

235 related items for PubMed ID: 15505498

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Beneficial effects of phosphodiesterase 5 inhibition in pulmonary hypertension are influenced by natriuretic Peptide activity.
    Zhao L, Mason NA, Strange JW, Walker H, Wilkins MR.
    Circulation; 2003 Jan 21; 107(2):234-7. PubMed ID: 12538421
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Acute phosphodiesterase 5 inhibition mimics hemodynamic effects of B-type natriuretic peptide and potentiates B-type natriuretic peptide effects in failing but not normal canine heart.
    Forfia PR, Lee M, Tunin RS, Mahmud M, Champion HC, Kass DA.
    J Am Coll Cardiol; 2007 Mar 13; 49(10):1079-88. PubMed ID: 17349888
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Cardiorenal and neurohumoral effects of endogenous atrial natriuretic peptide in dogs with severe congestive heart failure using a specific antagonist for guanylate cyclase-coupled receptors.
    Wada A, Tsutamoto T, Matsuda Y, Kinoshita M.
    Circulation; 1994 May 13; 89(5):2232-40. PubMed ID: 7910118
    [Abstract] [Full Text] [Related]

  • 10. Improvement of mortality by long-term E4010 treatment in monocrotaline-induced pulmonary hypertensive rats.
    Kodama K, Adachi H.
    J Pharmacol Exp Ther; 1999 Aug 13; 290(2):748-52. PubMed ID: 10411587
    [Abstract] [Full Text] [Related]

  • 11. Pulmonary hypertension: inhaled nitric oxide, sildenafil and natriuretic peptides.
    Steiner MK, Preston IR, Klinger JR, Hill NS.
    Curr Opin Pharmacol; 2005 Jun 13; 5(3):245-50. PubMed ID: 15907910
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Cyclic guanosine monophosphate compartmentation in rat cardiac myocytes.
    Castro LR, Verde I, Cooper DM, Fischmeister R.
    Circulation; 2006 May 09; 113(18):2221-8. PubMed ID: 16651469
    [Abstract] [Full Text] [Related]

  • 15. Acute hemodynamic effects of intravenous sildenafil citrate in congestive heart failure: comparison of phosphodiesterase type-3 and -5 inhibition.
    Botha P, Parry G, Dark JH, Macgowan GA.
    J Heart Lung Transplant; 2009 Jul 09; 28(7):676-82. PubMed ID: 19560695
    [Abstract] [Full Text] [Related]

  • 16. Increased cGMP phosphodiesterase activity mediates renal resistance to ANP in rats with bile duct ligation.
    Ni XP, Safai M, Gardner DG, Humphreys MH.
    Kidney Int; 2001 Apr 09; 59(4):1264-73. PubMed ID: 11260387
    [Abstract] [Full Text] [Related]

  • 17. Intravenous dipyridamole enhances the effects of inhaled nitric oxide and prevents rebound pulmonary hypertension in piglets.
    Foubert L, De Wolf D, Mareels K, Van Belleghem Y, Reyntjens K, Mortier E, Van Nooten G.
    Pediatr Res; 2002 Nov 09; 52(5):730-6. PubMed ID: 12409521
    [Abstract] [Full Text] [Related]

  • 18. Synergy between natriuretic peptides and phosphodiesterase 5 inhibitors ameliorates pulmonary arterial hypertension.
    Baliga RS, Zhao L, Madhani M, Lopez-Torondel B, Visintin C, Selwood D, Wilkins MR, MacAllister RJ, Hobbs AJ.
    Am J Respir Crit Care Med; 2008 Oct 15; 178(8):861-9. PubMed ID: 18689467
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.